<DOC>
	<DOC>NCT00196352</DOC>
	<brief_summary>This study is being conducted to evaluate the safety of ethinyl an extended-regimen oral contraceptive, with ethinyl estradiol supplementation during the usual hormone-free week, for up to an additional three consecutive years.</brief_summary>
	<brief_title>A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.</brief_title>
	<detailed_description>This study is being conducted to evaluate the safety of an extended-regimen oral contraceptive, with ethinyl estradiol supplementation during the usual hormone-free week, for up to an additional three consecutive years. This is an extension of the Seasonique Phase 3 clinical trial to evaluate long-term safety. Only patients enrolled in the earlier trial are eligible for participation.</detailed_description>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Contraceptives, Oral</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Ethinyl estradiol, levonorgestrel drug combination</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Participant in the earlier Phase 3 Seasonique clinical trial Any contraindication to the use of oral contraceptives</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>oral contraceptives</keyword>
	<keyword>birth control</keyword>
	<keyword>ethinyl estradiol</keyword>
	<keyword>pregnancy prevention</keyword>
</DOC>